# Memory Aid by Intranasal Insulin in Diabetes (MemAID)

Study · id `cardio:ct-nct02415556` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02415556](<https://clinicaltrials.gov/study/NCT02415556>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02415556

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 289 participants.

## Technical summary

Registry record NCT02415556. Randomized; quadruple masking; primary purpose treatment. Start 2015-10-06 (actual); primary completion 2020-05-31 (actual). Results posted on 2021-09-17.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 289 participants (enrolled count; ClinicalTrials.gov record NCT02415556, source copy `cardio:ctgov-nct02415556-2022-05-19`, retrieved 2026-10-26)
- Started: 2015-10-06 (actual) (ClinicalTrials.gov record NCT02415556, source copy `cardio:ctgov-nct02415556-2022-05-19`, retrieved 2026-10-26)
- Primary completion: 2020-05-31 (actual) (ClinicalTrials.gov record NCT02415556, source copy `cardio:ctgov-nct02415556-2022-05-19`, retrieved 2026-10-26)
- Completion: 2020-05-31 (actual) (ClinicalTrials.gov record NCT02415556, source copy `cardio:ctgov-nct02415556-2022-05-19`, retrieved 2026-10-26)
- Results first posted: 2021-09-17 (ClinicalTrials.gov record NCT02415556, source copy `cardio:ctgov-nct02415556-2022-05-19`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT02415556, source copy `cardio:ctgov-nct02415556-2022-05-19`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02415556-2022-05-19`, retrieved 2026-10-26)

## The registry's words

- Brief title: Memory Aid by Intranasal Insulin in Diabetes (MemAID)
- Acronym: MemAID
- Condition: Type 2 Diabetes Mellitus
- Intervention (Drug): Regular Human Insulin
- Intervention (Drug): Placebo
- Lead sponsor: Beth Israel Deaconess Medical Center
- Lead sponsor class: OTHER
- Collaborator: Novo Nordisk A/S
- Collaborator class: INDUSTRY
- Collaborator: Medtronic
- Collaborator class: INDUSTRY
- Collaborator: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Collaborator class: NIH

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Beth Israel Deaconess Medical Center (`cardio:org-beth-israel-deaconess-medical-center`)
- Registry lists this organization as a collaborator: Novo Nordisk (`cardio:novo-nordisk`)
- Registry lists this organization as a collaborator: Medtronic (`cardio:medtronic`)
- Registry lists this organization as a collaborator: National Institute of Diabetes and Digestive and Kidney Diseases (`cardio:niddk`)

### Other papers using this trial's data

- Registry lists this paper as a reference of type result; PubMed dates it on or after the trial start and types it as a trial report, neither its types nor its title mark it as a protocol, a review or a comment, the paper names no other trial in place of this one, and PubMed shows no retraction or expression of concern; it is not marked as the trial's main report: MemAID: Memory advancement with intranasal insulin vs. placebo in type 2 diabetes and control participants: a randomized clinical trial (`cardio:pubmed-35482079`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 743bad261d80286ddde528cd04bfd90d8d91fca7e9986cbd1245a75115ea896a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
